List of Brand Recomended for "Treatment of Patients with Unresectable or Metastatic Melanoma and disease progression following Ipilmumab and, if BRAF V600 Mutation Positive,a BRAF Inhibitor ".
1 Result founds.
Brand Name: OPDIVO-1*
Manufacture Name: BRISTOL-MEYER-SQUBB INC
Compositions:
Nivolumab- mg,
